[Department Memorandum No. 2021- 0158] Inclusion of 0.1% Sodium Hyaluronate (15 ml) and 2.5% Peritoneal Dialysis Solution (2L and 5L) in the Philippine National Formulary
[Department Circular No. 2021- 0079] Health Technology Assessment Council’s (HTAC) Recommendations on health technologies requiring Full Certificate of Registration (CPR) from the Food and Drug Administration
[Department Memorandum No. 2021- 0075] Compliance to dissemination of the recommendations of the Health Technology Assessment council (HTAC)
[Department Memorandum No. 2021- 0097] Health Technology Assessment Council’s (HTAC) Recommendations on COVID-19 heath technologies
Preliminary Recommendation on 0.1% Sodium Hyaluronate (15 mL) and 2.5% Peritoneal Dialysis Solution (2L and 5L)
